Elevated Plasma Membrane Cholesterol Content Alters Macrophage Signaling and Function Chunbo Qin, Tomokazu Nagao, Inna Grosheva, Frederick R. Maxfield, Lynda M. Pierini Downloaded from http://atvb.ahajournals.org/ by guest on June 18, 2017 Objective—During atherogenesis, macrophages migrate into the subendothelial space where they ingest deposited lipoproteins, accumulate lipids, and transform into foam cells. It is unclear why these macrophages do not remove their lipid loads from the region. This study was aimed at testing the hypothesis that macrophage behavior is altered when membrane cholesterol levels are elevated, as might be the case for cells in contact with lipoproteins within atherosclerotic lesions. Methods and Results—We examined the effects of elevating membrane cholesterol on macrophage behavior. J774 macrophages were treated with either acetylated low-density lipoprotein (ac-LDL) and ACAT inhibitor or cholesterol-chelated methyl--cyclodextrin (chol-MCD) to increase membrane cholesterol levels. Our results show that elevating the membrane cholesterol of J774 macrophages induced dramatic ruffling, stimulated cell spreading, and affected F-actin organization. Cellular adhesion was required for these effects, and Rac-mediated signaling pathways were involved. Additionally, 3-dimensional transwell chemotaxis assays showed that migration of J774 macrophages was significantly inhibited when membrane cholesterol levels were raised. Conclusions—These findings indicate that increased membrane cholesterol causes dramatic effects on macrophage cellular functions related to the actin cytoskeleton. They should provide new insights into the early steps of atherogenesis. (Arterioscler Thromb Vasc Biol. 2006;26:372-378.) Key Words: actin 䡲 atherosclerosis 䡲 cholesterol 䡲 macrophages 䡲 migration A generation, and inhibition of cell migration.5,6 These findings suggest that the atherosclerotic environment, and specifically interactions with modified lipoproteins, can explain the retention of macrophages in lesions. However, it is still unclear how interactions with modified lipoproteins alter macrophage function: Can the changes in actin organization and migration be attributed to a signaling event initiated by binding of modified lipoproteins to their receptor(s)? Or are they a result of modulations in cellular cholesterol content after cholesterol transfer from the lipoproteins? One particularly interesting observation is that as macrophages begin to engulf aggregated matrix-bound LDL particles, they maintain prolonged contact with the LDL aggregates.7 During this prolonged contact there can be rapid transfer of cholesterol and cholesteryl esters from the LDL aggregates to the macrophage, and transient increases in the cholesterol content of macrophage plasma membranes may result. Because reduction in membrane cholesterol levels has been shown to affect many cellular processes,8 –14 presumably by altering membrane lipid organization, we postulated that increasing membrane cholesterol content may likewise affect cell function. If elevated membrane cholesterol does indeed alter cell function, then this may explain why macrophages within atherosclerotic lesions are unable to egress from the affected area. lthough it has long been accepted that elevated serum cholesterol levels correlate with development of atherosclerotic lesions, the reasons for this are imperfectly understood. It is known that the cholesterol carrier, low-density lipoprotein (LDL), normally found circulating in the blood, is deposited in the subendothelial space.1,2 These LDL deposits undergo aggregation, association with extracellular matrix materials, and oxidation.3,4 Monocytes that have traversed the endothelium then engulf the matrix-bound aggregated lipoprotein particles and develop into lipid-filled macrophages (known as foam cells). Macrophage lipid accumulation, and subsequent foam cell formation, promotes growth of the atherosclerotic plaque, whereas lesion regression, induced pharmacologically or through diet, may be attributed partly to foam cell migration out of the area. This synopsis illustrates the critical role of cell migration in the progression of atherosclerosis and suggests that understanding the causes of macrophage accumulation within the atherosclerotic lesion is important for developing strategies to curtail the progression and/or promote the regression of the disease. Currently, it is unclear why macrophages that enter atherosclerotic lesions remain there rather than depart with their lipid loads. In vitro, treatment of macrophages with modified LDL caused alterations in actin organization, reduction of force Original received August 23, 2005; final version accepted November 9, 2005. From the Departments of Biochemistry (C.Q., T.N., I.G., F.R.M.) and Surgery (L.M.P.), Weill Medical College of Cornell University, New York, NY. Correspondence to Lynda M. Pierini, Department of Surgery, Box 287, Weill Medical College of Cornell University, New York, NY 10021. E-mail [email protected]; or Frederick R. Maxfield, Department of Biochemistry, Box 63, Weill Medical College of Cornell University, New York, NY 10021. E-mail [email protected] © 2006 American Heart Association, Inc. Arterioscler Thromb Vasc Biol. is available at http://www.atvbaha.org 372 DOI: 10.1161/01.ATV.0000197848.67999.e1 Qin et al Increasing Cholesterol Affects Macrophage Behavior As a first step to test this hypothesis, we investigated how global increases in membrane cholesterol modify macrophage biology, using cholesterol delivery to cells via methyl-cyclodextrin rather than delivery by lipoproteins. This allowed us to examine the effects of cholesterol elevation in the absence of possible effects from binding of apolipoproteins to their receptors. Interestingly, we found that elevated levels of membrane cholesterol affect F-actin organization and F-actin– dependent functions, but these changes in the actin cytoskeleton can be inhibited by blocking scavenger receptors even when cholesterol is delivered via methyl--cyclodextrin. Methods Cells and Cell Culture Mouse macrophage cell line J774A.1 was obtained from the American Type Culture Collection. See http://atvb.ahajournals.org for details on growth and maintenance of the cells. Downloaded from http://atvb.ahajournals.org/ by guest on June 18, 2017 Lipoproteins and Reagents Human LDL was prepared as previously described.15 Acetylated LDL (Ac-LDL) was prepared by acetylation of LDL with acetic anhydride as described previously.16 ACAT inhibitor 58035, originally from Sandoz Inc, was kindly provided by Dr Ira Tabas. Methyl--cyclodextrin (MCD) and cholesterol-chelated methyl-cyclodextrin (as “water-soluble cholesterol,” molar ratio 1:6 cholesterol/MCD) were purchased from Sigma. All treatment concentrations involving cholesterol-chelated-MCD (chol-MCD) were based on the weight of MCD. Fucoidan and Clostridium difficile toxin B were purchased from Sigma and Calbiochem, respectively. Phalloidin Staining and Filipin Staining To visualize F-actin, J774 cells were simultaneously fixed, permeabilized, and labeled by incubation with 3.3% paraformaldehyde, 0.05% glutaraldehyde, 0.25 mg/mL saponin, and 2 U/mL AlexaFluor 488 phalloidin (Molecular Probes) in phosphate-buffered saline for 15 minutes at room temperature. Images were then acquired with a Zeiss LSM510 laser scanning confocal microscope, or a Leica DMIRB widefield microscope equipped with a Princeton Instruments cooled charge-coupled device camera driven by MetaMorph Imaging System software (Universal Imaging Corporation, Downingtown, Pa). To quantify changes in cellular free cholesterol, cells were fixed with 3.3% paraformaldehyde for 15 minutes and then incubated with 50 g/mL filipin (Sigma) for 1.5 hours at room temperature. Wide-field images were then obtained. Details on quantitative analysis of phalloidin- or filipin-stained cells can be found in the supplemental materials. Macropinocytosis Assay J774 cells, grown on polylysine-coated glass coverslip-bottom dishes for 16 hours, were first treated with 5 mmol/L chol-MCD for indicated times or left untreated, then incubated with 1 mg/mL TRITC-conjugated Dextran (160 kDa; Sigma) for 15 minutes before fixation.17 Wide-field fluorescence images of all samples were acquired under identical conditions for quantitative analysis using MetaMorph. The images were thresholded so that only dextranpositive endosomes were included, and all images were thresholded to the same scale. The integrated fluorescence in the thresholded area was measured and divided by the total number of cells to yield a measure of fluorescence intensity per cell. Scanning Electron Microscopy J774 cells in suspension were left untreated or treated with 5 mmol/L chol-MCD for 30 minutes at 37°C, and then fixed for 10 minutes by addition of equal volume of 8% paraformaldehyde, 5% glutaralde- 373 hyde, and 0.04% picric acid in 0.1 mol/L sodium cacodylate buffer, pH 7.3. Samples were then prepared for scanning electron microscopy as described in the supplemental materials. Immunofluorescence For costaining of Rac and F-actin, J774 cells were fixed with 3.3% paraformaldehyde in the presence of 0.25 mg/mL saponin and 1 U/mL AlexaFluor 488 phalloidin for 15 minutes at room temperature. Excess AlexaFluor 488 phalloidin was included throughout the remaining labeling steps. Rac was visualized with a mouse monoclonal antibody against Rac1 (clone 102; BD Biosciences Pharmingen), followed by an AlexaFluor 546-conjugated goat anti-mouse secondary antibody (Molecular Probes). Images were then acquired with a Zeiss LSM510 laser scanning confocal microscope using a 63⫻1.4 numeric aperture objective. Determination of Activated Rac The PAK pull-down assay was performed using a Rac activation assay kit (Cytoskeleton) following the manufacturer’s instruction. Briefly, cells were grown to ⬍ 80% confluence on 100 mm tissue culture dishes (Falcon). After chol-MCD treatment, cells were lysed in lysis buffer, clarified by centrifugation, and incubated with GST-PAK beads for 1 hour at 4°C. Bound Rac was analyzed by SDS-PAGE separation on a 4% to 12% polyacrylamide gel, and visualized by Western blotting with monoclonal anti-Rac1 antibody and HRP-conjugated goat anti-mouse IgG (Sigma) using the ECL system (Pierce). For normalization, whole cell lysates were run in parallel. Macrophage Migration Assay Migration of J774 cells was tested in a chemotaxis assay using Transwell Inserts (Costar, Cambridge, Mass) with 5-m polycarbonate filter inserts. Further details regarding the conditions used for the migration assay are provided in the supplemental materials. Results Cholesterol Loading by Ac-LDL and ACAT Inhibitor Induces Membrane Ruffles and Stimulates Cell Spreading To load cell membranes with cholesterol, we treated J774 macrophages with 50 g/mL ac-LDL and 10 g/mL ACAT inhibitor 58035 for 5 hours. Ac-LDL no longer binds to LDL receptors, but it is taken into cells by scavenger receptors, which are not subject to down regulation by the level of cellular cholesterol.16,18 Ac-LDL uptake strongly triggers ACAT activity when cellular free cholesterol reaches certain threshold levels.19 Thus, cotreatment with ac-LDL and ACAT inhibitor leads to the accumulation of free cholesterol in the cells. Under the conditions used in these experiments, the cellular free cholesterol level in treated cells was increased ⬇2-fold over control cells, as determined by filipin staining (data not shown). To assess the validity of fluorescence image analysis of filipin-stained cells as a quantitative measure of cellular cholesterol content, the results from this technique were compared with those obtained by gas chromatographic analysis of cellular lysates.20 Both techniques yielded similar results (Figure I, available online at http://atvb.ahajournals. org), demonstrating that quantitative fluorescence imaging of filipin-stained cells is an accurate method for evaluating cellular free cholesterol levels under conditions used in this study. To observe the effects that treatment with ac-LDL and the ACAT inhibitor had on macrophage biology, treated and control cells were plated onto fibronectin-coated dishes for 10 374 Arterioscler Thromb Vasc Biol. February 2006 Downloaded from http://atvb.ahajournals.org/ by guest on June 18, 2017 Figure 1. Loading plasma membranes of macrophages with cholesterol by ac-LDL and ACAT inhibitor treatment stimulated cell spreading and membrane ruffling. J774 macrophages were treated with 50 g/mL ac-LDL and 10 g/mL 58035 for 5 hours then plated onto fibronectin-coated dishes for 10 minutes before fixation and staining for F-actin. Arrows indicate membrane ruffles. Scale bar, 10 m. minutes, fixed, and stained for F-actin. Figure 1 shows that cells treated with ac-LDL and the ACAT inhibitor become more spread and form more F-actin-rich membrane ruffles than untreated cells, whereas neither ac-LDL nor the ACAT inhibitor alone could cause these morphological changes (data not shown). These results suggest that raising the cholesterol content in the plasma membranes of macrophages alters their biology. Increased Cell Spreading and Membrane Ruffling in Ac-LDL/ACAT Inhibitor-Treated Cells Can Be Attributed to Increases in Free Cholesterol Although treatment with ac-LDL and the ACAT inhibitor induced a clear response in J774 macrophages, it was not clear if the spreading and ruffling were caused by signals initiated by ac-LDL, the ACAT inhibitor, or cholesterol loading. To determine whether raising membrane cholesterol levels, rather than signaling via the cholesterol delivery system (either the ac-LDL or the ACAT inhibitor), caused the observed effects, we used cholesterol-chelated methyl-cyclodextrin (chol-MCD) to acutely raise the cholesterol content of the plasma membrane. Treatment with 5 mmol/L chol-MCD for either 15 or 30 minutes increased total cellular cholesterol levels by 1.5- to 2-fold (Figure 2A), which results in levels comparable to those obtained after treatment with ac-LDL and the ACAT inhibitor. These changes in membrane cholesterol stimulated cell spreading, with the average cell area for cells treated with chol-MCD for 15 or 30 minutes increasing by 45% or 60%, respectively, compared with control cells (Figure 2A). The effects of cholesterol loading on cell spreading were readily reversed when membrane cholesterol was returned to starting levels by subsequent treatment with MCD, and there is a clear correlation between the cellular cholesterol content and the extent of cell spreading (Figure 2A). As for cells treated with ac-LDL and the ACAT inhibitor (Figure 1), J774 cells that were treated with chol-MCD for 15 minutes and then plated Figure 2. Increasing membrane cholesterol reversibly induced cell spreading and membrane ruffling. (A) Modulation of membrane cholesterol caused corresponding changes in cell area. J774 cells, grown on polylysine-coated dishes overnight, were left untreated (control), treated with 5 mmol/L chol-MCD (⫹), or treated sequentially with 5 mmol/L Chol- MCD (⫹) and then 10 mmol/L MCD (⫺) for indicated times before fixation. Cells were then stained with filipin to determine the relative free cholesterol levels per cell (gray bars) or labeled with a fluorescent conjugate of phalloidin to delineate the cell periphery for cell area measurements (white bars). Quantification of fluorescence images is described in supplemental materials. Data represent means⫾SD from at least 3 independent experiments. (B) Raising membrane cholesterol by treatment with chol-MCD induced membrane ruffling (arrowheads). J774 macrophages were left untreated (control) or treated with 5 mmol/L cholMCD for 15 minutes (cholesterol-loaded) in suspension, and then plated onto fibronectin-coated dishes for 10 minutes before fixation and staining for F-actin. Projected confocal images formed from 20 0.7-m confocal slices are presented. Scale bar, 10 m. onto fibronectin-coated dishes for 10 minutes exhibited F-actin-rich ruffles (Figure 2B). Confocal fluorescence images of the lower adherent surfaces of control and cholesterol-loaded cells show that F-actin is accumulated at the edges of the cholesterol-loaded J774 cells but not the control cells (Figure IIA, available online at http://atvb.ahajournals.org), and quantification of the F-actin at the cell edge shows that cholesterol-loaded cells have approximately twice the amount of F-actin near the cell edges compared with control cells (Figure IIB). Interestingly, although cholesterol loading caused increased membrane ruffling, there was no apparent increase in the total F-actin content (compare the intensity of the phalloidin staining in control versus treated cells in Figures 1 and 2B). Quantification of the total F-actin content in control and chol-MCD-treated J774 cells confirmed that there was no increase in the total amount of F-actin after chol-MCD treatment, implying that there was a change in the organization and/or localization of F-actin but not an increase in actin polymerization (Figure IIB). These results show that increasing membrane cholesterol levels causes morphological and cytoskeletal changes in macrophages. Qin et al Increasing Cholesterol Affects Macrophage Behavior 375 Figure 3. Increasing membrane cholesterol stimulated macropinocytosis. J774 cells were left untreated (control), or treated with 5 mmol/L chol-MCD for indicated times (chol-loaded), then incubated with 1 mg/mL TRITC-Dextran for 15 minutes before fixation. Data shown are from 1 representative experiment of 3. Error bars represent SD. Downloaded from http://atvb.ahajournals.org/ by guest on June 18, 2017 Cholesterol Loading Induced Macropinocytosis Activity Because one obvious effect of increasing membrane cholesterol levels on J774 macrophages was the induction of membrane ruffles, we predicted that macropinocytosis activity of J774 cells might also be induced on cholesterol loading. To test the effects of cholesterol loading on macropinocytosis, control or chol-MCD–treated cells were incubated with TRITC-conjugated dextran for 15 minutes. The samples were then fixed, and fluorescence images were taken for quantitative analysis. As shown in Figure 3, the amount of fluorescent dextran taken up by the cells was dramatically increased when the J774 cells were cholesterol-loaded, indicating that increasing membrane cholesterol levels causes an increase in membrane pinocytic activity. Effects of Cholesterol Loading on Membrane Ruffling and F-Actin Organization Require Cell Adhesion The results presented suggested that cholesterol itself might be acting as a signaling molecule. However, because our experiments were performed on adherent cells, it was also possible that cholesterol loading was potentiating signals initiated by adhesion molecules. To determine whether cell adhesion played a role in the cellular changes induced by cholesterol loading, we altered membrane cholesterol levels of J774 cells in suspension, and then fixed the samples for analysis by scanning electron microscopy or by confocal fluorescence microscopy after staining with fluorescent phalloidin (Figure 4A). We found no obvious differences in the surface morphologies or F-actin organization of control and cholMCD–treated cells, indicating that the effects of increased membrane cholesterol on membrane ruffling and F-actin reorganization required cell adhesion and increasing cellular cholesterol was not sufficient to induce this effect by itself. It has been shown that macrophage adhesion in vitro is mediated in large part by 2 integrins and scavenger receptor A.21 To test the role of these adhesion molecules, we used specific inhibitors to block their contribution during cholesterol loading. Our data suggest that RGD-binding integrins and 2 family integrins do not contribute to the cellular changes induced by cholesterol loading (Figure III, available Figure 4. Signaling via scavenger receptor-mediated adhesion or ligation is required for cellular responses to cholesterol loading. (A) J774 macrophages in suspension did not show morphological changes when treated with chol-MCD. Cells were either left untreated (control) or treated with 5 mmol/L chol-MCD for 30 minutes (cholesterol-loaded) before fixation. Scanning electron micrographs (SEM, top panels) and projected confocal images of F-actin staining (lower panels) are presented. (B) A general scavenger receptor inhibitor, fucoidan, blocked the effects of cholesterol loading. J774 cells were grown on polylysine-coated dishes overnight, in the presence (right panel) or absence (left and middle panels) of 250 g/mL fucoidan. The cells were either left untreated (control), or treated with 5 mmol/L chol-MCD for 30 minutes (chol-loaded) with or without fucoidan. Projected confocal images of phalloidin-stained cells are presented. Scale bar, 10 m. online at http://atvb.ahajournals.org). In contrast, the ruffling and spreading induced by cholesterol loading were inhibited by fucoidan (Figure 4B), indicating that cellular attachment via receptors other than scavenger receptors coupled with cholesterol-loading is not sufficient to mediate the observed cellular changes. To determine whether ligation of scavenger receptors and cholesterol loading would be sufficient to induce ruffling in the absence of cell attachment, we treated cells in suspension with fucoidan (a scavenger receptor ligand) and loaded them with cholesterol. This treatment did not induce any significant ruffling in suspended cells (Figure IV, available online at http://atvb.ahajournals.org), further indicating that signaling via scavenger receptor attachment and/or ligation of scavenger receptors by an unknown molecule in the substratum is involved. Rac Is Activated and Recruited to Membrane Ruffles When Membrane Cholesterol Levels Are Increased To begin to understand which signaling steps elevated membrane cholesterol levels affect, we investigated the effects of cholesterol modulation on Rac activation because it is wellestablished that Rho GTPases play important roles in actin polymerization. Rac activation has been particularly associated with the formation of membrane ruffles.22,23 376 Arterioscler Thromb Vasc Biol. February 2006 Downloaded from http://atvb.ahajournals.org/ by guest on June 18, 2017 First, we used indirect immunofluorescence to localize endogenous Rac1 in control and chol-MCD–treated macrophages using both J774 cells (Figure 5A), as well as primary human monocyte-derived macrophages (Figure V, available online at http://atvb.ahajournals.org). In control J774 cells, Rac 1 (shown in red) had a patchy distribution within the cell cytosol; Rac1 was found bounded within the F-actin (shown in green) and, even within the few visible membrane extensions (arrows), it did not colocalize with F-actin (note the lack of yellow color in “control” panel). In contrast, after cells were treated with chol-MCD, Rac1 was found almost entirely in membrane ruffles (arrows), and it colocalized extensively with F-actin (note yellow color in “cholesterol-loaded” panel.) Similar results were observed in human monocyte-derived macrophages (Figure V). The membrane recruitment of Rac1 after chol-MCD treatment suggests that elevating membrane cholesterol levels leads to Rac activation. The activation of Rac was further confirmed using a pulldown assay with the Rac-GTP binding domain of PAK.24 Figure 5B shows that Rac1 was activated within 1 minute of cholMCD treatment, peaked at ⬇15 minutes, and started to decrease at 30 minutes. In addition, treatment with Clostridium difficile toxin B completely abolished the ruffling stimulated by membrane cholesterol loading (Figure 5C). Toxin B specifically monoglucosylates and inactivates Rho-family GTPases,25 and it has been a commonly used inhibitor to study the cellular function of Rac.26 –28 Taken together, these results suggest that Rac-mediated signaling pathways, possibly in concert with other Rho-family GTPases, are involved in the observed morphological changes induced by cholesterol loading. Migration Is Inhibited in Macrophages With Elevated Membrane Cholesterol Levels These results demonstrate that raising membrane cholesterol levels causes changes in cellular morphology and the organization of F-actin in macrophages. Because cell morphology and F-actin organization are vital components of cell migration, and because cell migration is an important factor in atherogenesis, we investigated the effects of cholesterol loading on macrophage migration. We used 3-dimensional Transwell migration assays to study the effects of cholesterol loading on J774 macrophage chemotaxis. J774 cells were first treated with 5 mmol/L cholMCD for 15 minutes, and then induced to migrate in response to 10 nM recombinant C5a.29 After 2 hours, cells that had migrated through the Transwell filter were fixed and counted. Figure 6 shows that the migration of cholesterol-loaded J774 macrophages was inhibited by 60% compared with control cells, and this inhibition could be completely reversed when the membrane cholesterol of cholesterol-loaded cells was reduced by subsequent treatment with MCD. Discussion Numerous studies have investigated the effects of reducing membrane cholesterol levels on signal transduction, but far fewer have looked at the effects of the potentially more physiologically relevant event of increasing membrane cholesterol levels. Here we have investigated the effects of raising cellular cholesterol on cellular functions related to the actin cytoskeleton. Specifically, we have shown that raising the cholesterol content in macrophage mem- Figure 5. Rac GTPase was activated upon membrane cholesterol loading. (A) Rac (labeled in red) was recruited to ruffling membranes in cholesterol-loaded macrophages. J774 cells grown on polylysine-coated dishes were left untreated (control) or treated with 5 mmol/L chol-MCD for 30 minutes (chol-loaded) before fixation and immunofluorescence. Green color represents F-actin. Projected confocal images are presented. (B) Rac was activated in cholesterol-loaded cells. J774 cells grown on tissue culture dishes (107 cells/dish) were left untreated (control) or treated with 5 mmol/L chol-MCD (chol-loaded) for indicated times before harvest. A PAK pull-down assay was used to detect the amount of activated Rac under each treatment condition. A representative Western blot is shown. (C) Toxin B treatment completely abolished the ruffling stimulated by cholesterol-loading in J774 macrophages. J774 cells, grown on polylysine-coated dishes overnight, were left untreated (control), treated with 5 mmol/L chol-MCD for 30 minutes (chol-loaded), or treated with 5 mmol/L chol-MCD and 10 ng/mL toxin B for 30 minutes (chol-loaded⫹toxin B). The cells were then fixed and stained for F-actin. Projected confocal images are presented. Scale bar, 10 m. branes affects Rac-mediated F-actin organization, increases membrane pinocytic activity, and decreases cell migration. These changes are similar to those observed when macrophages were treated with modified lipoproteins,5,6 suggesting that the changes induced by modified lipoproteins can be attributed, in part, to alterations in cellular cholesterol levels. A key pathogenic event in the development of atherosclerosis is the retention of lipoprotein particles in the subintima.30 These lipoprotein particles subsequently undergo aggregation, association with extracellular matrix proteoglycans, and oxidative modification.31 The physiological significance of the findings presented in this study becomes evident at the stage of atherosclerotic lesion formation when monocytes/macrophages first contact aggregated matrix-bound LDL. Previous studies have shown that macrophage interactions with aggregated, matrixbound LDL particles initiate specific cellular events that can lead to increases in membrane cholesterol levels.7,32 Specifically, macrophage uptake of aggregated matrix-bound LDL was found to be slow compared with aggregated lipoproteins that are not matrix-bound; during the slow internalization process, matrixbound LDL was found to reside for extended times within deep Qin et al Increasing Cholesterol Affects Macrophage Behavior Downloaded from http://atvb.ahajournals.org/ by guest on June 18, 2017 Figure 6. Elevated membrane cholesterol inhibited the Transwell migration of J774 cells. J774 cells were loaded with cholesterol by incubation with 5 mmol/L chol-MCD for 15 minutes (cholloaded). To test the reversibility of this treatment, an aliquot of cholesterol-loaded cells was subsequently treated with 10 mmol/L MCD for 10 minutes to lower cholesterol levels (reversal). The migration of untreated, cholesterol-loaded, and cholesterol-reversed cells was tested in a Transwell migration assay in response to 10 nM C5a. Results were normalized to the number of untreated (control) cells that had migrated across the Transwell filter after incubation for 2 hours. Data shown are from one representative experiment. Error bars represent SD. invaginations in the macrophage cell surface.7 Because the rate of cholesterol ester hydrolysis was found to greatly exceed the rate of protein degradation during the uptake of aggregated matrix-bound LDL, it is thought that the prolonged contact of the aggregates with the macrophage cell surface allows selective uptake of cholesterol ester from the extracellular lipoprotein.7 In other words, there is transfer of cholesterol ester directly from LDL aggregates to the macrophage plasma membrane, rapid cholesterol ester hydrolysis, and a consequent increase in membrane cholesterol levels. Additional studies showed that uptake of aggregated matrix-bound LDL requires the actin-myosin cytoskeleton, presumably for extension of macrophage plasma membrane around the matrix-retained aggregates in a process reminiscent of phagocytosis.32 We show here that when membrane cholesterol levels are elevated, there is an increase in actin-mediated membrane activities, including membrane ruffling and macropinocytosis. This observation is consistent with a recent finding that ACAT1-deficient peritoneal macrophages, which accumulate free cholesterol on ac-LDL treatment, appeared to have increased surface activities.33 Based on these observations, one can propose a model for a pathogenic circle of events: First, macrophages come into contact with matrix-bound LDL aggregates, cholesterol ester transfer occurs, macrophage membrane cholesterol levels increase, and actin-mediated membrane extensions are stimulated. This causes a broader area of cell-surface contact with the aggregates, more cholesterol ester transfer, a further increase in membrane cholesterol levels, additional membrane extensions, greater cell-surface contact with the aggregates, and so on. This scenario could explain, in part, why macrophages within atherosclerotic lesions continue to take up retained lipoproteins and become foam cells. How Does Cholesterol Induce Cellular Changes? Cholesterol loading does not increase actin-based ruffling in suspended cells, and the ruffling induced by cholesterol loading of attached cells is blocked by incubation with fucoidan, a ligand for scavenger receptors. These data indicate that cholesterol 377 itself does not serve as a signaling molecule to induce the effects observed in this study. Instead, increasing membrane cholesterol levels may alter plasma membrane organization in a way that potentiates signaling by adhesion molecules. Our data suggest that scavenger receptors contribute to the cholesterol-sensitive signals that lead to changes in cell function. In this regard it is interesting to note that scavenger receptors can activate signaling pathways leading to actin polymerization and focal adhesion formation, presumably by binding ligands in the extracellular matrix.34 The Rho family GTPases, Rho, cdc42, and Rac, are known to be major mediators of signaling leading to actin reorganization.35,36 The Rho GTPases are thought to regulate the formation of distinct actin filament-containing structures. Because the morphological responses in macrophages induced by membrane cholesterol loading resembled the effects of Rac activation, we investigated the involvement of Rac signaling in cholesterolinduced membrane ruffling. By each of 3 different methods (PAK pull-down assay, visualization of Rac recruitment to the plasma membrane, and Toxin B inhibition), we found that Rac was involved in the morphological and cytoskeletal changes induced by cholesterol loading. These findings are consistent with our previous ones in human neutrophils, namely, that when the levels of cholesterol in plasma membranes of neutrophils are reduced, both stimulated membrane ruffling and Rac recruitment to the plasma membrane are inhibited.12 Membrane Cholesterol and Cell Migration Despite having potentiating effects on membrane activity and F-actin reorganization, cholesterol loading caused the inhibition of macrophage migration. Cell migration is a highly integrated, multi-step process consisting of cell polarization, membrane extension at the front of the cell, regulated formation and release of adhesions along the length of the cell, and retraction of the cell rear (uropod). These steps are orchestrated in part by the interactive regulation of the Rho-family GTPases.37–39 Our data clearly show that Rac activity and localization are altered after cholesterol loading, and it is likely that the activities of the other Rho family members are also affected by changes in membrane cholesterol levels. Misregulation of these signaling molecules could lead to the inability of the cells to correctly polarize, retract their uropods, or regulate their attachments with the substratum. Several studies have shown that plasma membrane organization is critical for cell migration,11,12,40 and our previous work on neutrophils showed that depleting membrane cholesterol inhibited neutrophil migration because the cells were unable to form membrane extensions and polarize.12 Further studies are required for understanding the exact defect in the migration of cholesterol-loaded macrophages. The observations reported here indicate that increased membrane cholesterol causes dramatic effects on the actin cytoskeleton in macrophages associating with extracellular matrix. It is possible that after initial contact of a macrophage with lipoproteins in the vessel wall, cholesterol transfer to the cell causes changes similar to those observed in this study. The increased membrane ruffling and extensions could increase the contact of the macrophage with the lipoprotein deposit, leading to further cholesterol delivery. The decreased motility of the cell would keep it in the region of the 378 Arterioscler Thromb Vasc Biol. February 2006 lipoprotein deposit. Additional studies will be required to determine to what extent contact with lipoprotein particles causes local increases in membrane cholesterol levels and the consequences of these local changes for cell function. These findings should provide new insights into the early steps of atherogenesis and might eventually lead to innovative methods of preventing lesion formation or promoting lesion regression. Acknowledgments This work was supported by National Institutes of Health grants P01-HL072942. We thank Leona Cohen-Gould for technical help with the scanning electron microscopy experiment. We also thank Dr William Muller for helpful discussions. References Downloaded from http://atvb.ahajournals.org/ by guest on June 18, 2017 1. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417:750 –754. 2. Boren J, Gustafsson M, Skalen K, Flood C, Innerarity TL. Role of extracellular retention of low density lipoproteins in atherosclerosis. Curr Opin Lipidol. 2000;11:451– 456. 3. Chait A, Wight TN. Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipidol. 2000;11:457–463. 4. Tabas I. Nonoxidative modifications of lipoproteins in atherogenesis. Annu Rev Nutr. 1999;19:123–139. 5. Pataki M, Lusztig G, Robenek H. Endocytosis of oxidized LDL and reversibility of migration inhibition in macrophage-derived foam cells in vitro. A mechanism for atherosclerosis regression? Arterioscler Thromb. 1992;12:936 –944. 6. Zerbinatti CV, Gore RW. Uptake of modified low-density lipoproteins alters actin distribution and locomotor forces in macrophages. Am J Physiol Cell Physiol. 2003;284:C555–C561. 7. Buton X, Mamdouh Z, Ghosh R, Du H, Kuriakose G, Beatini N, Grabowski GA, Maxfield FR, Tabas I. Unique cellular events occurring during the initial interaction of macrophages with matrix-retained or methylated aggregated low density lipoprotein (LDL). Prolonged cellsurface contact during which LDL-cholesteryl ester hydrolysis exceeds ldl protein degradation. J Biol Chem. 1999;274:32112–32121. 8. Gatfield J, Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science. 2000;288:1647–1650. 9. Sheets ED, Holowka D, Baird B. Critical role for cholesterol in Lynmediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J Cell Biol. 1999;145:877– 887. 10. Burgos PV, Klattenhoff C, de la Fuente E, Rigotti A, Gonzalez A. Cholesterol depletion induces PKA-mediated basolateral-to-apical transcytosis of the scavenger receptor class B type I in MDCK cells. Proc Natl Acad Sci U S A. 2004;101:3845–3850. 11. Manes S, Mira E, Gomez-Mouton C, Lacalle RA, Keller P, Labrador JP, Martinez AC. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J. 1999;18:6211– 6220. 12. Pierini LM, Eddy RJ, Fuortes M, Seveau S, Casulo C, Maxfield FR. Membrane lipid organization is critical for human neutrophil polarization. J Biol Chem. 2003;278:10831–10841. 13. Hao M, Mukherjee S, Sun Y, Maxfield FR. Effects of cholesterol depletion and increased lipid unsaturation on the properties of endocytic membranes. J Biol Chem. 2004;279:14171–14178. 14. Grimmer S, van Deurs B, Sandvig K. Membrane ruffling and macropinocytosis in A431 cells require cholesterol. J Cell Sci. 2002;115: 2953–2962. 15. Tabas I, Lim S, Xu XX, Maxfield FR. Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages. J Cell Biol. 1990;111:929 –940. 16. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76:333–337. 17. Araki N, Johnson MT, Swanson JA. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol. 1996;135:1249 –1260. 18. Brown MS, Goldstein JL, Krieger M, Ho YK, Anderson RG. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J Cell Biol. 1979;82:597– 613. 19. Xu XX, Tabas I. Lipoproteins activate acyl-coenzyme A:cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level. J Biol Chem. 1991;266: 17040 –17048. 20. Ishikawa TT, MacGee J, Morrison JA, Glueck CJ. Quantitative analysis of cholesterol in 5 to 20 microliter of plasma. J Lipid Res. 1974;15: 286 –291. 21. Fraser I, Hughes D, Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature. 1993;364:343–346. 22. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 1995;81:53– 62. 23. Allen WE, Jones GE, Pollard JW, Ridley AJ. Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci. 1997;110(Pt 6):707–720. 24. Benard V, Bohl BP, Bokoch GM. Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J Biol Chem. 1999;274:13198 –13204. 25. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature. 1995;375:500 –503. 26. West MA, Prescott AR, Eskelinen EL, Ridley AJ, Watts C. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr Biol. 2000;10:839 – 848. 27. Sohn HY, Keller M, Gloe T, Morawietz H, Rueckschloss U, Pohl U. The small G-protein Rac mediates depolarization-induced superoxide formation in human endothelial cells. J Biol Chem. 2000;275:18745–18750. 28. Djouder N, Schmidt G, Frings M, Cavalie A, Thelen M, Aktories K. Rac and phosphatidylinositol 3-kinase regulate the protein kinase B in Fc epsilon RI signaling in RBL 2H3 mast cells. J Immunol. 2001;166:1627–1634. 29. McCloskey MA, Fan Y, Luther S. Chemotaxis of rat mast cells toward adenine nucleotides. J Immunol. 1999;163:970 –977. 30. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551–561. 31. Williams KJ, Tabas I. The response-to-retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol. 1998;9:471– 474. 32. Sakr SW, Eddy RJ, Barth H, Wang F, Greenberg S, Maxfield FR, Tabas I. The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity. J Biol Chem. 2001;276:37649 –37658. 33. Dove DE, Su YR, Zhang W, Jerome WG, Swift LL, Linton MF, Fazio S. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. Arterioscler Thromb Vasc Biol. 2005;25: 128 –134. 34. Post SR, Gass C, Rice S, Nikolic D, Crump H, Post GR. Class A scavenger receptors mediate cell adhesion via activation of G(i/o) and formation of focal adhesion complexes. J Lipid Res. 2002;43:1829 –1836. 35. Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279: 509 –514. 36. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629 – 635. 37. Nobes CD, Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol. 1999;144:1235–1244. 38. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol. 2004;265:23–32. 39. Weiss-Haljiti C, Pasquali C, Ji H, Gillieron C, Chabert C, Curchod ML, Hirsch E, Ridley AJ, van Huijsduijnen RH, Camps M, Rommel C. Involvement of phosphoinositide 3-kinase gamma, Rac, and PAK signaling in chemokine-induced macrophage migration. J Biol Chem. 2004; 279:43273– 43284. 40. Vasanji A, Ghosh PK, Graham LM, Eppell SJ, Fox PL. Polarization of plasma membrane microviscosity during endothelial cell migration. Dev Cell. 2004;6:29 – 41. Downloaded from http://atvb.ahajournals.org/ by guest on June 18, 2017 Elevated Plasma Membrane Cholesterol Content Alters Macrophage Signaling and Function Chunbo Qin, Tomokazu Nagao, Inna Grosheva, Frederick R. Maxfield and Lynda M. Pierini Arterioscler Thromb Vasc Biol. 2006;26:372-378; originally published online November 23, 2005; doi: 10.1161/01.ATV.0000197848.67999.e1 Arteriosclerosis, Thrombosis, and Vascular Biology is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Copyright © 2005 American Heart Association, Inc. All rights reserved. Print ISSN: 1079-5642. Online ISSN: 1524-4636 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://atvb.ahajournals.org/content/26/2/372 Data Supplement (unedited) at: http://atvb.ahajournals.org/content/suppl/2005/11/23/01.ATV.0000197848.67999.e1.DC1 Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Arteriosclerosis, Thrombosis, and Vascular Biology can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at: http://www.lww.com/reprints Subscriptions: Information about subscribing to Arteriosclerosis, Thrombosis, and Vascular Biology is online at: http://atvb.ahajournals.org//subscriptions/ Supplemental Materials Elevated Plasma Membrane Cholesterol Content Alters Macrophage Signaling and Function Chunbo Qin, Tomokazu Nagao, Inna Grosheva, Frederick R. Maxfield, and Lynda M. Pierini From the Departments of Biochemistry (C.Q., T.N., I.G., F.R.M.) and Surgery (L.M.P.), Weill Medical College of Cornell University, New York, NY Methods Cells and Cell Culture J774 cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum, 50 units/ml penicillin and 50 µg/ml streptomycin in a humidified atmosphere (5% CO2 plus 95% air) at 37 °C. Stock cultures were grown on polystyrene petri dishes (VWR) and split every 2-3 days. On the day prior to experiments utilizing adherent J774 cells, the cells were plated onto polylysine-coated glass-bottom dishes [made by affixing No.1 coverslips (Gold Seal) beneath holes in the bottom of 35 mm petri dishes (Corning)],1 and incubated in complete culture medium for 16 hrs. The next day, the cells were washed two times with serumfree HEPES-buffered DMEM (pH 7.4), and incubated with cholesterol-modifying reagents in serum-free HEPES-buffered DMEM for indicated times at 37°C. For experiments utilizing suspended cells, cells were grown to ~ 85% confluence in complete culture medium, washed twice with serum-free HEPES-buffered DMEM, and then suspended by trituration in the same buffer (2.5 x 105 cells/ml) for further treatment. Human peripheral blood mononuclear cells (PBMCs) were isolated by density gradient sedimentation in Ficoll (Amersham Biosciences) as described previously.2 Lymphocytes were washed away after PBMCs were plated onto fibronectin-coated dishes for 30 min. Monocytes, which remained attached to the fibronectin-coated dishes, were differentiated in vitro by incubation in DMEM containing 10% heat-inactivated FBS and 10 ng/ml macrophage colony stimulating factor (M-CSF, R&D Systems) for 7 days. Materials RGD peptide (Gly-Arg-Gly-Asp-Ser) was from Sigma. Purified rat anti-mouse CD18 monoclonal antibody (GAME-46) was purchased from BD Pharmingen. Lipid Extraction and Free Cholesterol Measurement J774 cells, grown overnight on 12-well tissue culture plates (Becton Dickinson), were washed with PBS after chol-MβCD treatment and then extracted with two 30 min incubation in 0.5 ml hexane:isopropanol (3:2) at room temperature. Half of the cellular lipid extract from each sample was analyzed for free cholesterol by gas-liquid chromatography,3 while the other half was analyzed for phospholipid content.4 Fluorescence Image Analysis For quantitative analysis of phalloidin- or filipin-stained J774 cells, wide-field fluorescence images of all samples within one experiment were acquired with a 25 x 0.75 numeric aperture objective under identical conditions, and the images were then quantified using MetaMorph image analysis software. Following background correction, the average fluorescence intensity per cell was measured for more than 100 cells per condition, and these measurements were normalized to the level of the unstimulated control cells. In order to measure the area of the cells, fluorescence images, acquired at a focal plane close to the adherent surface of phalloidin-labeled cells, were thresholded to exclude all the cell-free regions. The total thresholded area was measured and divided by the number of the cells. All data represent means +/- S.D. from at least three independent experiments. Scanning Election Microscopy The fixed cells were suction-filtered onto polylysine-coated Nucleopore polycarbonate filters (0.45 μm, Whatman). Filters were washed three times in the same sodium cacodylate buffer and post-fixed in 1% osmium tetroxide and 1.5% potassium ferricyanide (aqueous solution) for 1 hr. Samples were dehydrated through a graded series of ethanol-water washes (50%, 70%, 85%, 95% ethanol, respectively, followed by 3 times of 100% ethanol), critical point dried through carbon dioxide, and lightly coated with gold palladium. Samples were then examined at 20 kV using a JEOL 100 CX-II electron microscope fitted with an ASID-scanning unit, and photographs were recorded on Polaroid Type 55 P/N film. Macrophage Migration Assay J774 cells (105 cells/well) were plated on the transwell filters, and incubated for 2 h in normal growth medium. The cells were treated with 5 mM chol-MβCD in 20 mM HEPES-buffered DMEM for 15 min, and then washed once with DMEM containing 0.5% FBS. These filter inserts were placed in wells containing 600 μl of 10 nM human recombinant C5a (Sigma) diluted in DMEM. Migration was allowed to proceed for 2 h at 37° C in a CO2 incubator. After this incubation period, the filters were fixed with 1% glutaraldehyde, and cells that had not migrated were removed from the upper surface of the filter by scraping. The filters were then stained with 1 μM TO-PRO-3 iodide (Molecular Probes), mounted onto coverslip dishes, and observed via confocal microscopy (LSM510, Carl Zeiss). The numbers of cells that had migrated across the filters were determined by counting the number of cells in at least 5 random fields of confocal images acquired with a 10x objective at the bottom of each filter. Figure Legends Figure I. Quantification of cellular free cholesterol content by GC analysis of cellular extracts and fluorescence imaging of filipin-stained cells. J774 cells were left untreated (control) or treated with 5 mM chol-MβCD (chol-loaded) for the indicated times. For GC analysis (hatched bar), free cholesterol levels are expressed as a fraction of the phospholipid content in the same sample to normalize for variations in cell number. For filipin-stained cells (white and dark bars), data represent integrated filipin fluorescence per cell. GC analysis and quantitative imaging were performed on samples prepared on the same day. Error bars represent s.d. Figure II. Increasing membrane cholesterol reversibly induced membrane ruffling. A, Treatment with chol-MβCD causes accumulation of F-actin along the cell edges. J774 cells, grown on polylysine-coated dishes overnight, were left untreated (control), treated with 5 mM chol-MβCD for indicated times (cholesterol-loaded), or treated sequentially with 5 mM chol-MβCD for 15 min and then 10 mM MβCD for 30 min (reversal) before fixation and staining for F-actin. Projected confocal images of the lower adherent surface (consisting of 3 bottom slices at the step size of 1.25 μm) are presented. Scale bar, 10 μm. B, Cholesterol-loaded cells show an increase in edge-accumulated, but not total cellular, F-actin. Edge intensity (white bar) was measured by quantifying the integrated fluorescence within a series of 5 x 5 pixel boxes created randomly along the edge of each cell. Figure III. Inhibitors of integrins did not block the effects of cholesterol loading. J774 cells were grown on Fn-coated dishes for 1 hr in the presence of 200 µg/ml RGD peptide (c), 50 µg/ml anti-β2 function-blocking antibody (f), or without any inhibitors (a,b,d,e). The cells were either left untreated (control), or treated with 5 mM chol-MβCD for 30 min (chol-loaded) with or without the indicated inhibitors. Wide-field fluorescence images of phalloidin-stained cells are presented. Scale bar, 10 μm. Figure IV. Cholesterol loading and fucoidan treatment did not induce ruffling in suspended J774 macrophages. J774 cells, suspended in DMEM-HEPES, were left untreated (a), treated with 250 μg/ml fucoidan alone (c), or treated with 5mM cholMβCD for 30 min in the absence (b) or presence (d) of 250 μg/ml fucoidan. The cells were then fixed in suspension and stained with phalloidan. Projected confocal images are presented. Scale bar, 10 μm. Figure V. Cholesterol loading induced cell spreading and stimulated Rac recruitment to membranes in primary human monocyte-derived macrophages. Human monocytederived macrophages grown on Fn-coated dishes were left untreated (control) or treated with 5 mM chol-MβCD for 30 min (chol-loaded) before fixation and labeling by immunofluorescence. Projected confocal images are presented. Rac is shown in red, while F-actin is shown in green. Scale bar, 10 μm. References 1. 2. 3. 4. Salzman NH, Maxfield FR. Intracellular fusion of sequentially formed endocytic compartments. J Cell Biol. 1988;106:1083-1091. Muller WA, Weigl SA. Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay. J Exp Med. 1992;176:819-828. Ishikawa TT, MacGee J, Morrison JA, Glueck CJ. Quantitative analysis of cholesterol in 5 to 20 microliter of plasma. J Lipid Res. 1974;15:286-291. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234:466-468. Figure I Figure II Figure III Figure IV Figure V
© Copyright 2026 Paperzz